- |||||||||| phenoxodiol (NV06) / MEI
Phase classification, Enrollment change, Trial termination, Trial primary completion date, Combination therapy, Metastases: Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (clinicaltrials.gov) - Apr 4, 2017 P1, N=31, Terminated, Trial primary completion date: Aug 2016 --> Dec 2017 Phase classification: P1/2 --> P1 | N=60 --> 31 | Recruiting --> Terminated | Trial primary completion date: Jun 2008 --> Aug 2009
- |||||||||| Enrollment change: Selection of Embryos by Time-lapse (clinicaltrials.gov) - Mar 31, 2017
P=N/A, N=59, Completed, Phase classification: P1/2 --> P1 | N=60 --> 31 | Recruiting --> Terminated | Trial primary completion date: Jun 2008 --> Aug 2009 N=100 --> 59
- |||||||||| quisinostat (JNJ 26481585) / ChemRar, Viriom
Trial primary completion date, Combination therapy, BRCA Biomarker, Epigenetic controller, Metastases: Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy (clinicaltrials.gov) - Mar 29, 2017 P2, N=31, Active, not recruiting, Recruiting --> Completed Trial primary completion date: Feb 2017 --> Sep 2017
- |||||||||| Trial completion, Trial primary completion date: Lidocaine Gel During Transrectal Sonography (clinicaltrials.gov) - Mar 27, 2017
P3, N=80, Completed, Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Aug 2016
- |||||||||| Cycloset (bromocriptine) / Bausch Health
Trial primary completion date: Vaginal Bromocriptine for Treatment of Adenomyosis (clinicaltrials.gov) - Mar 27, 2017 P1, N=33, Active, not recruiting, Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Aug 2016 Trial primary completion date: Mar 2017 --> Sep 2017
- |||||||||| Trial primary completion date: Hysteroscopic Assessment of Fallopian Tubal Patency (clinicaltrials.gov) - Mar 24, 2017
P=N/A, N=1000, Recruiting, Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Nov 2016 --> Nov 2018
- |||||||||| topotecan / Generic mfg., carboplatin / Generic mfg., cyclophosphamide / Generic mfg.
Trial primary completion date: Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (clinicaltrials.gov) - Mar 22, 2017 P1, N=48, Active, not recruiting, Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Dec 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| Trial completion, Phase classification, Trial primary completion date: Predictors of Success of IUI in Unexplained Infertility (clinicaltrials.gov) - Mar 21, 2017
P=N/A, N=100, Completed, Trial primary completion date: Sep 2017 --> Dec 2017 Not yet recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: Aug 2016 --> Feb 2017
- |||||||||| Trial completion, Video: Video Colposcopy in Women With Dysplasia (clinicaltrials.gov) - Mar 17, 2017
P=N/A, N=275, Completed, Recruiting --> Active, not recruiting Recruiting --> Completed
|